Stock SLS SELLAS LIFE SCIENCES GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart SELLAS Life Sciences Group, Inc.

Equities

SLS

US81642T2096

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-13 pm EDT 		5-day change 1st Jan Change
1.37 USD +1.11% Intraday chart for SELLAS Life Sciences Group, Inc. +6.20% +29.25%
May. 01 SELLAS Life Sciences Group, Inc. Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level CI
Apr. 29 SELLAS Life Sciences Group, Inc. Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
SELLAS LIFE SCIENCES GROUP, INC.
Bio Therapeutic Drugs
+1.11%+6.20%+29.25%-9.87%-96.99% 78.26M
Bearish
Bullish
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. SLS Stock
  4. Charts SELLAS Life Sciences Group, Inc.
  5. Comparison Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW